NMR · Insider Trading

Nomura Holdings, Inc

Every open-market purchase and sale reported by NMR officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings
50
most recent
Open-Market Buys
0
code P
Sales
0
code S
Reporting Insiders
19
current holders
NMR — Recent Form 4 Transactions (latest 2026-09-28)
FiledInsiderRole TypeSharesValue
2026-09-28 Akio Hori See Remarks A — —
2026-09-28 Yukiko Ozaki See Remarks A — —
2026-09-28 Akihito Tobari See Remarks A — —
2026-09-28 Masahiro Ishizuka Director A — —
2026-09-28 Shoji Ogawa Director A — —
2026-09-28 Hiroyasu Koike See Remarks A — —
2026-08-26 Masahiro Ishizuka Director A — —
2026-08-26 Akio Hori See Remarks A — —
2026-08-26 Hiroyasu Koike See Remarks A — —
2026-08-26 Yukiko Ozaki See Remarks A — —
2026-08-26 Shoji Ogawa Director A — —
2026-08-26 Akihito Tobari See Remarks A — —
2026-07-27 Yukiko Ozaki See Remarks A — —
2026-07-27 Shoji Ogawa Director A — —
2026-07-27 Akio Hori See Remarks A — —
2026-07-27 Hiroyasu Koike See Remarks A — —
2026-07-27 Masahiro Ishizuka Director A — —
2026-07-27 Akihito Tobari See Remarks A — —
2026-06-29 Yukiko Ozaki See Remarks A — —
2026-06-29 Koji Nagai Director A — —
2026-06-29 Akio Hori See Remarks A — —
2026-06-29 Hiroyasu Koike See Remarks A — —
2026-06-29 Akihito Tobari See Remarks A — —
2026-06-29 Masahiro Ishizuka Director A — —
2026-06-29 Shoji Ogawa Director A — —
2026-05-27 Takako Mori See Remarks A — —
2026-05-27 Naotaka Minami See Remarks A — —
2026-05-27 Akio Hori See Remarks A — —
2026-05-27 Akihito Tobari See Remarks A — —
2026-05-27 Sotaro Kato See Remarks A — —
2026-05-27 Shoji Ogawa Director A — —
2026-05-27 Masahiro Ishizuka Director A — —
2026-05-27 Christopher Paul Willcox See Remarks A — —
2026-05-27 Masahiro Goto See Remarks A — —
2026-05-27 Takumi Kitamura See Remarks A — —
2026-05-27 Kentaro Okuda See Remarks A — —
2026-05-27 Yuko Horiuchi See Remarks A — —
2026-05-27 Toshiyasu Iiyama See Remarks A — —
2026-05-27 Go Sugiyama See Remarks A — —
2026-05-27 Yutaka Nakajima See Remarks A — —
2026-05-27 Hiroyuki Moriuchi See Remarks A — —
2026-05-27 Yukiko Ozaki See Remarks A — —
2026-05-27 Hiroyasu Koike See Remarks A — —
2026-05-27 Koji Nagai Director A — —
2026-04-28 Shoji Ogawa Director A — —
2026-04-28 Masahiro Ishizuka Director A — —
2026-04-28 Naotaka Minami See Remarks MIXED — —
2026-04-28 Akihito Tobari See Remarks MIXED — —
2026-04-28 Go Sugiyama See Remarks MIXED — —
2026-04-28 Takako Mori See Remarks MIXED — —
NMR — Current Insider Holders
InsiderRole Shares HeldValue
— See Remarks 682,743 —
— See Remarks 529,192 —
— Director 512,942 —
— See Remarks 301,656 —
— See Remarks 243,374 —
— See Remarks 145,534 —
— See Remarks 114,899 —
— See Remarks 106,098 —
— See Remarks 62,774 —
— See Remarks 60,299 —
— Director 59,459 —
— See Remarks 53,814 —
— See Remarks 30,676 —
— See Remarks 29,078 —
— See Remarks 22,925 —
— See Remarks 21,093 —
— See Remarks 18,448 —
— See Remarks 14,586 —
— Director 11,278 —
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the NMR quote page; the site-wide leaderboard is on the insider transactions hub.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.